Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Psychosocial Treatment for Women With Depression and Pain
Psychosocial Treatment for Gynecology Patients With Comorbid Depression and Pain
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Psychosocial Treatment for Women With Depression and Pain
Psychosocial Treatment for Gynecology Patients With Comorbid Depression and Pain
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Sylvester Comprehensive Cancer Center. University of Miami Miller School of Medicine
mi
from
Miami, FL
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Sylvester Comprehensive Cancer Center. University of Miami Miller School of Medicine
mi
from
Miami, FL
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Montefiore Medical Center
mi
from
Bronx, NY
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Montefiore Medical Center
mi
from
Bronx, NY
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
OU Cancer Institute
mi
from
Oklahoma, OK
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
OU Cancer Institute
mi
from
Oklahoma, OK
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Fox Chase Cancer Center
mi
from
Philadephia, PA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Fox Chase Cancer Center
mi
from
Philadephia, PA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Analgesic Effect of Perioperative Systemic Lidocaine in Patients Undergoing Unilateral Mastectomy Surgery
Analgesic Effect of Perioperative Systemic Lidocaine in Patients Undergoing Unilateral Mastectomy Surgery
Status: Archived
Northwestern University
mi
from
Chicago, IL
Analgesic Effect of Perioperative Systemic Lidocaine in Patients Undergoing Unilateral Mastectomy Surgery
Analgesic Effect of Perioperative Systemic Lidocaine in Patients Undergoing Unilateral Mastectomy Surgery
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
Status: Archived
University of Utah
mi
from
Salt Lake City, UT
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
Status: Archived
Updated: 1/1/1970
University of Utah
mi
from
Salt Lake City, UT
Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
11 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
Status: Archived
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
11 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
Status: Archived
Updated: 1/1/1970
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Weight Management for Improved Pregnancy Outcomes
Weight Management for Improved Pregnancy Outcomes
Status: Archived
Kaiser Permanente
mi
from
, CO
Weight Management for Improved Pregnancy Outcomes
Weight Management for Improved Pregnancy Outcomes
Status: Archived
Updated: 1/1/1970
Kaiser Permanente
mi
from
, CO
Induction of Labor With Oxytocin: When Should Oxytocin be Held?
Induction of Labor With Oxytocin: When Should Oxytocin be Held?
Status: Archived
Lehigh Valley Health Network
mi
from
Allentown, PA
Induction of Labor With Oxytocin: When Should Oxytocin be Held?
Induction of Labor With Oxytocin: When Should Oxytocin be Held?
Status: Archived
Updated: 1/1/1970
Lehigh Valley Health Network
mi
from
Allentown, PA
Efficacy and Safety of S-Equol on Vasomotor Symptoms in Menopausal Patients
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Vasomotor Symptoms in Menopausal Patients
Status: Archived
Greater Cincinnati OB/GYN, Inc.
mi
from
Cincinnati,, OH
Efficacy and Safety of S-Equol on Vasomotor Symptoms in Menopausal Patients
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Vasomotor Symptoms in Menopausal Patients
Status: Archived
Updated: 1/1/1970
Greater Cincinnati OB/GYN, Inc.
mi
from
Cincinnati,, OH
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
A Double-blind, Parallel Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
Status: Archived
Yale University School of Medicine
mi
from
New Haven, CT
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
A Double-blind, Parallel Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
mi
from
New Haven, CT
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Drs. Straughn & Wingard, PC
mi
from
Birmingham, AL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Drs. Straughn & Wingard, PC
mi
from
Birmingham, AL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
University of South Alabama
mi
from
Mobile, AL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
University of South Alabama
mi
from
Mobile, AL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Womens Health Research
mi
from
Phoenix, AZ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Womens Health Research
mi
from
Phoenix, AZ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Visions Clinical Research Tuscon
mi
from
Tucson, AZ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Visions Clinical Research Tuscon
mi
from
Tucson, AZ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
San Diego Perinatal Center
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
San Diego Perinatal Center
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Women's Healthcare at Frost Street
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Women's Healthcare at Frost Street
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Poway Womens Care
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Poway Womens Care
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
IGO
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
IGO
mi
from
San Diego, CA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Visions Clinical Research
mi
from
Boynton Beach, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Visions Clinical Research
mi
from
Boynton Beach, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
University of Miami Hospital
mi
from
Miami, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
mi
from
Miami, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
South Florida Perinatal Medicine
mi
from
Miami, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
South Florida Perinatal Medicine
mi
from
Miami, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Global Ob/Gyn Centers
mi
from
Pembroke Pines, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Global Ob/Gyn Centers
mi
from
Pembroke Pines, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Discovery Clinical Research
mi
from
Sunrise, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Discovery Clinical Research
mi
from
Sunrise, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Sheridan Clinical Research
mi
from
Sunrise, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Sheridan Clinical Research
mi
from
Sunrise, FL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Fetal Diagnostic Institute of the Pacific
mi
from
Honolulu, HI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Fetal Diagnostic Institute of the Pacific
mi
from
Honolulu, HI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Women's Clinic
mi
from
Boise, ID
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Women's Clinic
mi
from
Boise, ID
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Reproductive Genetics Institute
mi
from
Chicago, IL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Reproductive Genetics Institute
mi
from
Chicago, IL
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Steven Lamm, M.D.
mi
from
New York, NY
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Steven Lamm, M.D.
mi
from
New York, NY
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
NECCR of Fall River
mi
from
Fall River, MA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
NECCR of Fall River
mi
from
Fall River, MA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Healthcare for Women Inc.
mi
from
New Bedford, MA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Healthcare for Women Inc.
mi
from
New Bedford, MA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Spectrum Health Hospital
mi
from
Grand Rapids, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Spectrum Health Hospital
mi
from
Grand Rapids, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
St Louis University
mi
from
St Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
St Louis University
mi
from
St Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Women's Healthcare Specialists of St. Louis LLC
mi
from
St. Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Women's Healthcare Specialists of St. Louis LLC
mi
from
St. Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
The Methodist Hospital Research Institute
mi
from
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
The Methodist Hospital Research Institute
mi
from
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Cooper University Hospital
mi
from
Camden, NJ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Cooper University Hospital
mi
from
Camden, NJ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Lyndhurst Gynecologic Associates
mi
from
Winston Salem, NC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Lyndhurst Gynecologic Associates
mi
from
Winston Salem, NC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Complete Healthcare for Women
mi
from
Columbus, OH
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Complete Healthcare for Women
mi
from
Columbus, OH
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Clinical Trials of America
mi
from
Eugene, OR
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Clinical Trials of America
mi
from
Eugene, OR
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC